Keith Crandell, Director, 10% Owner at DA32 Life Science Tech Acquisition Corp. (DALS), bought 2,250,000 shares at $10.00 ($22.5M) on 2021-07-30, disclosed to the SEC on 2021-08-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 650,000 | $6.5M | 28.9% |
| 2 | $10.00 | 1,600,000 | $16.0M | 71.1% |
| Total | $10.00 avg | 2,250,000 | $22.5M | 100% |
| Filing → |
| MASS | BUY | 2020-12-22 | $6.0M | — | Filing → |
| TWST | SELL | 2020-12-09 | $15.5M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |